← Leaderboards
Jaymie Voorhees
St. Louis College Of Pharmacy
$247,416
Attributed
$247,416
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $70.1K · FY2018–21$100K$75K$50K$25K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$247,416 · 1
By mechanism
F32$247,416 · 1
Top collaborators
No co-investigators on record.
Most similar at St. Louis College Of Pharmacy
Same institution · by research overlap
- Bahaa Elgendy$3,011,885
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposGenesCognitiveAffectBioenergeticsBrainBrain CellAnimal Disease ModelsAutomobile DrivingCell Culture TechniquesExtracellularCellsCell SurvivalCircadian RhythmsAgonistCognitive DeficitsDepositionDiagnosisEffective TherapyCause Of DeathElementsEnergy MetabolismGene ExpressionGenetic Models
Grant awards (4)
Targeting REV-ERB regulation of mitochondria as a therapeutic strategy in Alzheimer's disease$51,606
F32 · FY2021 · AG · contact PI
Targeting REV-ERB regulation of mitochondria as a therapeutic strategy in Alzheimer's disease$70,146
F32 · FY2020 · AG · contact PI
Targeting REV-ERB regulation of mitochondria as a therapeutic strategy in Alzheimer's disease$64,310
F32 · FY2019 · AG · contact PI
Targeting REV-ERB regulation of mitochondria as a therapeutic strategy in Alzheimer's disease$61,354
F32 · FY2018 · AG · contact PI